Get the latest market news, interviews and stock alerts. Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies. Small Caps and affiliated companies accept ...
Aircore (AC) drilling by junior explorer OzAurum Resources (ASX: OZM) has confirmed a new high-grade gold target within its Mulgabbie North project in Western Australia. The company completed 51 holes ...
Wellnex Life (ASX: WNX) has reported record sales of $3 million per month for November and December 2024, with 56% of the revenue coming from its own high-margin brands. The total of $11.94m in sales ...
Tartana Minerals (ASX: TAT) is in advanced discussions with Mt Garnet Mining Finance (MGMF) to manage the Mungana processing plant in the Chillagoe region of far north Queensland which is currently ...
Nanoveu (ASX: NVU) has appointed globally respected industry leader Mark Goranson to head up its semiconductor technologies ...
A number of media sources have reported the United Kingdom is being hit with a serious gold shortage, forcing London traders to direct bullion to the US to overcome the impact of Donald Trump’s new ...
New Murchison Gold (ASX: NMG) has accelerated plans to develop the high-grade Crown Prince deposit at its Garden Gully gold project in Western Australia with the completion of a positive feasibility ...
Nimy Resources (ASX: NIM) has opened up a pathway for the supply of high-value gallium to the US government’s defence sector from its projects in Australia. The company has executed a strategic, ...
Australian uranium miner Boss Energy (ASX: BOE) has achieved a number of key milestones that will de-risk the delivery of its ...
Altech Batteries (ASX: ATC) is progressing funding arrangements for the construction of its CERENERGY sodium-chloride ...
NH3 Clean Energy (ASX: NH3) (formerly Hexagon Energy Materials) has completed the engineering component of a preliminary front-end engineering and design (pre-FEED) study for its flagship WAH2 ...
Alterity Therapeutics (ASX: ATH) has announced positive topline results from a Phase 2 clinical trial of lead candidate ...